Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema

• Status: Unknown status
• Trial end date: 2015-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Ultra-wide field fluorescein angiography can detect the response of anti VGEF therapy such as Avastin on retinal ischemia in the setting of diabetic macular edema.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: King Khaled Eye Specialist Hospital
• Treatments: Bevacizumab

Criteria

Inclusion Criteria:

1. Diabetic patients at age >18year with DME

2. Scheduled for Avastin therapy

3. Adequate media to obtain OCT and UWFA

Exclusion Criteria:

1. Macular pathology of any etiology

2. Preexisting systemic disease causing retinal ischemia

3. Previous laser or anti-VEGF treatment in past 3 months

4. Previous retina surgery in past 2 months

5. Allergy to fluorescein dye

6. Psychiatric disorder, Alzheimer disease and Dementia or any other disorder precluding follow-up or continuation of the study.